
CAS: 1675248-19-7

Tofacitinib Amide (3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide)
CAS:1675248-19-7
Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, …
Formula:
C16H22N6O2
Color and Shape:
White Off-White Solid
Molecular weight:
330.18042
Ref: 45-1A03890
25mg | 3,128.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025

3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
CAS:1675248-19-7
Formula:
C16H22N6O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
330.3849
Ref: IN-DA00ABHG
10mg | To inquire |
Estimated delivery in United States, on Tuesday 29 Apr 2025

Tofacitinib Impurity 61
CAS:1675248-19-7
Formula:
C16H22N6O2
Color and Shape:
White To Off-White Solid
Molecular weight:
330.39
Ref: 4Z-T-117025
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 28 Apr 2025

Tofacitinib impurity L
Controlled ProductCAS:1675248-19-7
Impurity Tofacitinib Impurity (T528000) Applications Tofacitinib impurity L is an impurity of Tofacitinib (T528000), an …
Formula:
C16H22N6O2
Color and Shape:
Neat
Molecular weight:
330.38
Ref: TR-T528015
10mg | 1,192.00 € | ||
25mg | 2,138.00 € | ||
2500µg | 325.00 € |
Estimated delivery in United States, on Wednesday 7 May 2025

3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide
CAS:1675248-19-7
Purity:
98%
Molecular weight:
330.3919982910156
Ref: 10-F789597
10mg | 2,888.00 € |
Estimated delivery in United States, on Wednesday 7 May 2025

Tofacitinib impurity L
CAS:1675248-19-7
Please enquire for more information about Tofacitinib impurity L including the price, delivery time and …
Formula:
C16H22N6O2
Purity:
Min. 95%
Molecular weight:
330.38 g/mol
Ref: 3D-ASC24819
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information |